Moderna | Page 2 | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Tuesday
July 05, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
TUESDAY, JULY 05, 2022

Moderna

Vials of coronavirus disease (Covid-19) vaccines of Pfizer-BioNTech and Moderna are seen in the town of Ricany near Prague, Czech Republic, February 25, 2021. REUTERS/David W Cerny/File Photo
Coronavirus chronicle

Moderna starts trial for Omicron-specific booster shot

The variant currently accounts for 99.9% of the Covid-19 cases in the Unites States

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Covid-flu joint booster jab possible late 2023: Moderna

 Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store in West Haven, Connecticut, US, February 17, 2021. Photo :Reuters
Coronavirus chronicle

Moderna expects Covid-19 vaccine trial data for children aged 2-5 in March

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna CEO Bancel says people may need another booster in fall of 2022

The more we vaccinate, the more chance we have of stopping more variants from emerging. Photo: Bloomberg
Coronavirus chronicle

Moderna says booster dose of its Covid-19 vaccine appears protective vs. Omicron

 Walmart pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine inside a Walmart department store in West Haven, Connecticut, US, February 17, 2021. Photo :Reuters
Coronavirus chronicle

Moderna Covid-19 shot likelier to cause heart inflammation than Pfizer's: study

Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. Photo :Reuters
World+Biz

Japan approves Moderna Covid vaccine as booster, Novavax files for 1st approval

A healthcare worker holds a vial of the Moderna Covid-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (Covid-19) pandemic in Manhattan in New York City, New York, US, January 29, 2021. Photo :Reuters
Coronavirus chronicle

Moderna to produce millions of mRNA vaccines in Australia

REUTERS/Dado Ruvic/Illustration
World+Biz

Moderna asks investors to wait for full data on flu vaccine amid selloff

REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Moderna exec says company could have Omicron booster ready in March

A man puts on a face mask to prevent the spread of the coronavirus disease (Covid-19), while working at a community nucleic acid testing center in Hong Kong, China November 29, 2021.  Photo :Reuters
Coronavirus chronicle

Moderna CEO warns Covid-19 shots less effective against Omicron , markets tumble

Burton pointed out on Sunday that current vaccines should protect against the variant, adding that all unvaccinated people should take the jab. Photo :AP via Hindustan Times
Coronavirus chronicle

Covid: Vaccine for Omicron might be ready in early 2022, says Moderna

Vials of the Pfizer-BioNTech Covid-19 vaccine sit in a cooler before being thawed at a pop-up Covid-19 vaccination site in the Bronx borough of New York on Tuesday, Jan. 26, 2021. On Tuesday, Nov. 9, 2021, Pfizer asked US regulators to allow boosters of its Covid-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings. Photo: UNB/AP
Coronavirus chronicle

Pfizer/BioNTech, Moderna expect data on shot's protection against new Covid-19 variant soon

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
Workers ready a passenger vessel with a fresh coat of paint to the deck ahead of the Eid-ul-Azha at a dockyard at Mirerbagh in South Keraniganj. The vessel getting the makeover plies the Bhandaria route and will take holidaying people from the city to their country homes. Eid will be celebrated on 10 June this year. The photo was taken on Monday. Photo: Mumit M

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net